查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1338912

蘋果酸舒尼替尼市場、份額、規模、趨勢、產業分析報告：按應用；按地區；細分市場預測，2023-2032 年

Sunitinib Malate Market Share, Size, Trends, Industry Analysis Report, By Application (Pancreatic Neuroendocrine Tumor, Kidney Cancer, Gastro-intestinal Stromal Tumor); By Region; Segment Forecast, 2023-2032
出版日期: | 出版商: Polaris Market Research | 英文 115 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，到2032年，全球蘋果酸舒尼替尼市場規模預計將達到2.7854億美元。 該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

FDA 批准蘋果酸舒尼替尼和其他標靶癌症治療藥物可能會積極影響投資者對製藥業的信心。 在癌症研究領域，2022 年出現了一些重大進展。 美國食品藥物管理局 (FDA) 已批准 40 種用於癌症適應症的藥物，其中 12 種是從未在人類中使用過的全新分子。 最近的一篇部落格文章提供了前幾年 FDA 批准的清單。 這可能會導致研發投資增加，從而發現新的癌症治療方法，進一步推動市場成長。

在全球範圍內，癌症是導致死亡的主要原因之一，也是蘋果酸舒尼替尼市場成長的主要原因。 蘋果酸舒尼替尼用於治療某些類型的癌症，包括腎細胞癌和胃腸道間質瘤，全球癌症發病率不斷上升正在推動抗癌藥物的需求，我們正在推廣它。 據世界衛生組織 (WHO) 稱，癌症是全球頭號死亡原因，預計 2020 年將有 1,930 萬新發病例和 1,000 萬癌症相關死亡。 由於老化、生活方式的改變和環境因素等因素，癌症的發生率預計將繼續增加。

已開發國家和新興國家醫療保健支出的增加預計將推動蘋果酸舒尼替尼市場的成長。 醫療保健支出的增加是由於多種因素造成的，包括人口老化、慢性病盛行率上升以及政府不斷採取措施改善癌症照護。 根據2022年11月更新的資料庫“OECD Health Data 2022”，20個國家的初步估計顯示，2021年醫療費用平均成長約6%。

新的和創新的癌症治療方法的開發，包括蘋果酸舒尼替尼等標靶療法，正在推動市場成長。 與傳統化療相比，這些治療方法具有更高的療效和更少的副作用。 據美國癌症研究協會稱，由於過去幾十年癌症研究和治療的發展，到 2022 年初，美國癌症倖存者人數將超過預測的 1800 萬人。 儘管癌症檢測和治療取得了進展，但要減輕可預防癌症的負擔，仍有許多工作要做。

蘋果酸舒尼替尼市場報告亮點

由於胰臟神經內分泌腫瘤盛行率不斷增加，胰臟神經內分泌腫瘤領域佔比較高。

北美癌症發生率較高，因此預期會有較高的成長和較大的銷售份額。

由於老年人口不斷增長，預計歐洲在研究期間將佔據第二大銷售份額。

目錄

第一章簡介

第 2 章執行摘要

第三章研究方法

第 4 章全球蘋果酸舒尼替尼市場洞察

  • 蘋果酸舒尼替尼市場 - 產業概況
  • 蘋果酸舒尼替尼市場動態
    • 推動者和機會
      • 對有效癌症治療的需求不斷增加
      • 政府對醫療保健基礎設施的投資
    • 抑制因素和挑戰
  • 杵分析
  • 價值鏈分析
  • 蘋果酸舒尼替尼產業趨勢
  • COVID-19 感染的影響分析

第五章全球蘋果酸舒尼替尼市場，依應用劃分

  • 主要發現
  • 簡介
  • 胰臟神經內分泌腫瘤
  • 腎癌
  • 胃腸道間質瘤

第 6 章全球蘋果酸舒尼替尼市場（按地區）

  • 主要發現
  • 簡介
    • 2019-2032 年蘋果酸舒尼替尼市場評估（按地區）
  • 蘋果酸舒尼替尼市場 - 北美
    • 北美：蘋果酸舒尼替尼市場，依應用劃分，2019-2032 年
    • 蘋果酸舒尼替尼市場 - 美國
    • 蘋果酸舒尼替尼市場 - 加拿大
  • 蘋果酸舒尼替尼市場 - 歐洲
    • 歐洲：蘋果酸舒尼替尼市場，依應用劃分，2019-2032 年
    • 蘋果酸舒尼替尼市場 - 英國
    • 蘋果酸舒尼替尼市場 - 法國
    • 蘋果酸舒尼替尼市場 - 德國
    • 蘋果酸舒尼替尼市場 - 義大利
    • 蘋果酸舒尼替尼市場 - 西班牙
    • 蘋果酸舒尼替尼市場 - 荷蘭
    • 蘋果酸舒尼替尼市場 - 奧地利
  • 蘋果酸舒尼替尼市場 - 亞太地區
    • 亞太地區：蘋果酸舒尼替尼市場，依應用劃分，2019-2032 年
    • 蘋果酸舒尼替尼市場 - 中國
    • 蘋果酸舒尼替尼市場 - 印度
    • 蘋果酸舒尼替尼市場 - 馬來西亞
    • 蘋果酸舒尼替尼市場 - 日本
    • 蘋果酸舒尼替尼市場 - 印度尼西亞
    • 蘋果酸舒尼替尼市場 - 韓國
  • 蘋果酸舒尼替尼市場 - 中東和非洲
    • 中東和非洲：蘋果酸舒尼替尼市場，按應用劃分，2019-2032 年
    • 蘋果酸舒尼替尼市場 - 沙烏地阿拉伯
    • 蘋果酸舒尼替尼市場 - 阿拉伯聯合大公國
    • 蘋果酸舒尼替尼市場 - 以色列
    • 蘋果酸舒尼替尼市場 - 南非
  • 蘋果酸舒尼替尼市場 - 拉丁美洲
    • 拉丁美洲：蘋果酸舒尼替尼市場，按應用劃分，2019-2032 年
    • 蘋果酸舒尼替尼市場 - 墨西哥
    • 蘋果酸舒尼替尼市場 - 巴西
    • 蘋果酸舒尼替尼市場 - 阿根廷

第七章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協議/揭露

第八章公司簡介

  • Pfizer
  • Top Care Pharmacy
  • J&K Scientific
  • Targetmol
  • Active Biotech
  • Astellas Pharma
  • AstraZeneca
  • Bristol Myers Squibb
  • Dendreon
  • Endo International
  • Ferring Pharmaceuticals
Product Code: PM3356

The global sunitinib malate market size is expected to reach USD 278.54 Million by 2032, according to a new study by Polaris Market Research. The report "Sunitinib Malate Market Share, Size, Trends, Industry Analysis Report, By Application (Pancreatic Neuroendocrine Tumor, Kidney Cancer, Gastrointestinal Stromal Tumor); By Region; Segment Forecast, 2023-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The FDA's approval of sunitinib malate and other targeted cancer therapies can have a positive impact on investor confidence in the pharmaceutical industry. In the area of cancer research, 2022 saw some significant advancements. For oncology indications, the U.S. Food and Drug Administration (FDA) approved 40 drugs, 12 of which were brand-new molecules that had never been used in humans before. A recent blog post lists the FDA approvals from the previous year. This can lead to increased investment in research and development, which can lead to the discovery of new cancer treatments and further drive the growth of the market.

Globally, cancer is one of the leading causes of death and the primary cause of growth in the sunitinib market. Sunitinib Malate is used in the treatment of certain types of cancer, including renal cell carcinoma and gastrointestinal stromal tumors, and the increasing incidence of cancer worldwide is driving the demand for cancer therapies. According to the World Health Organization (WHO), cancer is a leading cause of death worldwide, with an estimated 19.3 million new cases and 10 million cancer-related deaths in 2020. The incidence of cancer is expected to continue to increase in the coming years, driven by factors such as an aging population, lifestyle changes, and environmental factors.

The increasing healthcare expenditure in developed and developing countries is expected to drive the growth of the sunitinib malate market. The rise in healthcare expenditure is due to various factors such as the aging population, rising prevalence of chronic diseases, and increasing government initiatives to improve cancer care. The database OECD Health Data 2022, updated in November 2022, states that preliminary estimates for a group of 20 countries indicate that health spending rose by about 6% on average in 2021.

The development of new and innovative cancer treatments, including targeted therapies such as sunitinib malate, is driving the growth of the market. These therapies offer improved efficacy and fewer side effects compared to traditional chemotherapy. According to the American Association for Cancer Research, early in 2022, there will be more cancer survivors in the United States than the predicted 18 million, due to developments in cancer research and treatment over the previous decades. There is still much to be done to lessen the burden of preventable cancer, despite the advancements it has achieved in the detection and treatment of the disease.

Sunitinib Malate Market Report Highlights

Pancreatic Neuroendocrine Tumor segment accounted for the higher growth rate owing to the increasing incidence of PNET.

North America is projected to experience higher growth and larger revenue share due to the high prevalence of cancer.

Europe is expected to registered with the second-largest revenue share in the study period due to the growing elderly population.

The global players include: Pfizer, Top Care Pharmacy, J&K Scientific, Targetmol, Active Biotech, Astellas Pharma, AstraZeneca, Bristol Myers Squibb, Dendreon, Endo International & Ferring Pharmaceuticals.

Polaris Market Research has segmented the sunitinib malate market report based on application and region:

Sunitinib Malate, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Pancreatic Neuroendocrine Tumor
  • Kidney Cancer
  • Gastrointestinal Stromal Tumor
  • Sunitinib Malate, Regional Outlook (Revenue - USD Million, 2019 - 2032
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Sunitinib Malate Market Insights

  • 4.1. Sunitinib Malate Market - Industry Snapshot
  • 4.2. Sunitinib Malate Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing demand for effective cancer treatments
      • 4.2.1.2. Government investment in healthcare infrastructure
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1.
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Value Chain Analysis
  • 4.6. Sunitinib Malate Industry trends
  • 4.7. COVID-19 Impact Analysis

5. Global Sunitinib Malate Market, by Application

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
  • 5.3. Pancreatic Neuroendocrine Tumor
    • 5.3.1. Global Sunitinib Malate Market, by Pancreatic Neuroendocrine Tumor, by Region, 2019-2032 (USD Million)
  • 5.4. Kidney Cancer
    • 5.4.1. Global Sunitinib Malate Market, by Kidney Cancer, by Region, 2019-2032 (USD Million)
  • 5.5. Gastrointestinal Stromal Tumor
    • 5.5.1. Global Sunitinib Malate Market, by Gastrointestinal Stromal Tumor, by Region, 2019-2032 (USD Million)

6. Global Sunitinib Malate Market, by Geography

  • 6.1. Key findings
  • 6.2. Introduction
    • 6.2.1. Sunitinib Malate Market Assessment, By Geography, 2019-2032 (USD Million)
  • 6.3. Sunitinib Malate Market - North America
    • 6.3.1. North America: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
    • 6.3.2. Sunitinib Malate Market - U.S.
      • 6.3.2.1. U.S.: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
    • 6.3.3. Sunitinib Malate Market - Canada
      • 6.3.3.1. Canada: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
  • 6.4. Sunitinib Malate Market - Europe
    • 6.4.1. Europe: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
    • 6.4.2. Sunitinib Malate Market - UK
      • 6.4.2.1. UK: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
    • 6.4.3. Sunitinib Malate Market - France
      • 6.4.3.1. France: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
    • 6.4.4. Sunitinib Malate Market - Germany
      • 6.4.4.1. Germany: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
    • 6.4.5. Sunitinib Malate Market - Italy
      • 6.4.5.1. Italy: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
    • 6.4.6. Sunitinib Malate Market - Spain
      • 6.4.6.1. Spain: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
    • 6.4.7. Sunitinib Malate Market - Netherlands
      • 6.4.7.1. Netherlands: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
    • 6.4.8. Sunitinib Malate Market - Austria
      • 6.4.8.1. Austria: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
  • 6.5. Sunitinib Malate Market - Asia Pacific
    • 6.5.1. Asia Pacific: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
    • 6.5.2. Sunitinib Malate Market - China
      • 6.5.2.1. China: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
    • 6.5.3. Sunitinib Malate Market - India
      • 6.5.3.1. India: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
    • 6.5.4. Sunitinib Malate Market - Malaysia
      • 6.5.4.1. Malaysia: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
    • 6.5.5. Sunitinib Malate Market - Japan
      • 6.5.5.1. Japan: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
    • 6.5.6. Sunitinib Malate Market - Indonesia
      • 6.5.6.1. Indonesia: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
    • 6.5.7. Sunitinib Malate Market - South Korea
      • 6.5.7.1. South Korea: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
  • 6.6. Sunitinib Malate Market - Middle East & Africa
    • 6.6.1. Middle East & Africa: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
    • 6.6.2. Sunitinib Malate Market - Saudi Arabia
      • 6.6.2.1. Saudi Arabia: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
    • 6.6.3. Sunitinib Malate Market - UAE
      • 6.6.3.1. UAE: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
    • 6.6.4. Sunitinib Malate Market - Israel
      • 6.6.4.1. Israel: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
    • 6.6.5. Sunitinib Malate Market - South Africa
      • 6.6.5.1. South Africa: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
  • 6.7. Sunitinib Malate Market - Latin America
    • 6.7.1. Latin America: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
    • 6.7.2. Sunitinib Malate Market - Mexico
      • 6.7.2.1. Mexico: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
    • 6.7.3. Sunitinib Malate Market - Brazil
      • 6.7.3.1. Brazil: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
    • 6.7.4. Sunitinib Malate Market - Argentina
      • 6.7.4.1. Argentina: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)

7. Competitive Landscape

  • 7.1. Expansion and Acquisition Analysis
    • 7.1.1. Expansion
    • 7.1.2. Acquisitions
  • 7.2. Partnerships/Collaborations/Agreements/Exhibitions

8. Company Profiles

  • 8.1. Pfizer
    • 8.1.1. Company Overview
    • 8.1.2. Financial Performance
    • 8.1.3. Product Benchmarking
    • 8.1.4. Recent Development
  • 8.2. Top Care Pharmacy
    • 8.2.1. Company Overview
    • 8.2.2. Financial Performance
    • 8.2.3. Product Benchmarking
    • 8.2.4. Recent Development
  • 8.3. J&K Scientific
    • 8.3.1. Company Overview
    • 8.3.2. Financial Performance
    • 8.3.3. Product Benchmarking
    • 8.3.4. Recent Development
  • 8.4. Targetmol
    • 8.4.1. Company Overview
    • 8.4.2. Financial Performance
    • 8.4.3. Product Benchmarking
    • 8.4.4. Recent Development
  • 8.5. Active Biotech
    • 8.5.1. Company Overview
    • 8.5.2. Financial Performance
    • 8.5.3. Product Benchmarking
    • 8.5.4. Recent Development
  • 8.6. Astellas Pharma
    • 8.6.1. Company Overview
    • 8.6.2. Financial Performance
    • 8.6.3. Product Benchmarking
    • 8.6.4. Recent Development
  • 8.7. AstraZeneca
    • 8.7.1. Company Overview
    • 8.7.2. Financial Performance
    • 8.7.3. Product Benchmarking
    • 8.7.4. Recent Development
  • 8.8. Bristol Myers Squibb
    • 8.8.1. Company Overview
    • 8.8.2. Financial Performance
    • 8.8.3. Product Benchmarking
    • 8.8.4. Recent Development
  • 8.9. Dendreon
    • 8.9.1. Company Overview
    • 8.9.2. Financial Performance
    • 8.9.3. Product Benchmarking
    • 8.9.4. Recent Development
  • 8.10. Endo International
    • 8.10.1. Company Overview
    • 8.10.2. Financial Performance
    • 8.10.3. Product Benchmarking
    • 8.10.4. Recent Development
  • 8.11. Ferring Pharmaceuticals
    • 8.11.1. Company Overview
    • 8.11.2. Financial Performance
    • 8.11.3. Product Benchmarking
    • 8.11.4. Recent Development

List of Tables

  • Table 1 Global Smart Railway Market, by Application, 2019-2032 (USD Million)
  • Table 2 Sunitinib Malate Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 3 North America: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
  • Table 4 U.S.: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
  • Table 5 Canada: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
  • Table 6 Canada: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
  • Table 7 Europe: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
  • Table 8 Spain: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
  • Table 9 Netherlands: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
  • Table 10 Austria: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
  • Table 11 Germany: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
  • Table 12 Italy: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
  • Table 13 France: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
  • Table 14 Asia Pacific: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
  • Table 15 China: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
  • Table 16 Japan: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
  • Table 17 India: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
  • Table 18 Indonesia: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
  • Table 19 South Korea: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
  • Table 20 Malaysia: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
  • Table 21 Latin America: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
  • Table 22 Brazil: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
  • Table 23 Mexico: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
  • Table 24 Argentina: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
  • Table 25 Middle East & Africa: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
  • Table 26 South Africa: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
  • Table 27 Israel: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
  • Table 28 Saudi Arabia: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)
  • Table 29 UAE: Sunitinib Malate Market, by Application, 2019-2032 (USD Million)

List of Figures

  • Figure 1 Global Sunitinib Malate Market, 2019-2032 (USD Million)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by Application
  • Figure 7 Global Sunitinib Malate Market, by Application, 2022 & 2032 (USD Million)
  • Figure 8 Sunitinib Malate Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 9 Strategic Analysis - Sunitinib Malate Market